Yixintang Pharmaceutical Group Co., Ltd.

SZSE:002727 Voorraadrapport

Marktkapitalisatie: CN¥8.6b

Yixintang Pharmaceutical Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Yixintang Pharmaceutical Group heeft een totaal eigen vermogen van CN¥7.9B en een totale schuld van CN¥495.5M, wat de schuld-eigenvermogensverhouding op 6.3% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥17.1B en CN¥9.3B. De EBIT Yixintang Pharmaceutical Group is CN¥507.1M waardoor de rentedekking 6.2 is. Het heeft contanten en kortetermijnbeleggingen van CN¥3.2B.

Belangrijke informatie

6.3%

Verhouding schuld/eigen vermogen

CN¥495.53m

Schuld

Rente dekkingsratio6.2x
ContantCN¥3.24b
AandelenCN¥7.87b
Totaal verplichtingenCN¥9.26b
Totaal activaCN¥17.13b

Recente financiële gezondheidsupdates

These 4 Measures Indicate That Yixintang Pharmaceutical Group (SZSE:002727) Is Using Debt Reasonably Well

Jul 15
These 4 Measures Indicate That Yixintang Pharmaceutical Group (SZSE:002727) Is Using Debt Reasonably Well

Recent updates

Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings

Sep 25
Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings

These 4 Measures Indicate That Yixintang Pharmaceutical Group (SZSE:002727) Is Using Debt Reasonably Well

Jul 15
These 4 Measures Indicate That Yixintang Pharmaceutical Group (SZSE:002727) Is Using Debt Reasonably Well

Some Investors May Be Worried About Yixintang Pharmaceutical Group's (SZSE:002727) Returns On Capital

Jun 29
Some Investors May Be Worried About Yixintang Pharmaceutical Group's (SZSE:002727) Returns On Capital

Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Intrinsic Value Is Potentially 26% Below Its Share Price

Jun 13
Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Intrinsic Value Is Potentially 26% Below Its Share Price

Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings Pushing Shares 27% Lower

Jun 13
Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings Pushing Shares 27% Lower

Yixintang Pharmaceutical Group (SZSE:002727) Is Due To Pay A Dividend Of CN¥0.40

May 27
Yixintang Pharmaceutical Group (SZSE:002727) Is Due To Pay A Dividend Of CN¥0.40

Yixintang Pharmaceutical Group's (SZSE:002727) Conservative Accounting Might Explain Soft Earnings

May 03
Yixintang Pharmaceutical Group's (SZSE:002727) Conservative Accounting Might Explain Soft Earnings

Investors Holding Back On Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727)

Apr 15
Investors Holding Back On Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727)

Return Trends At Yixintang Pharmaceutical Group (SZSE:002727) Aren't Appealing

Mar 06
Return Trends At Yixintang Pharmaceutical Group (SZSE:002727) Aren't Appealing

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥9.9B ) 002727 } overtreffen de korte termijn passiva ( CN¥7.6B ).

Langlopende schulden: De kortetermijnactiva 002727 ( CN¥9.9B ) overtreffen de langetermijnschulden ( CN¥1.6B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 002727 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 002727 is de afgelopen 5 jaar gedaald van 19.9% naar 6.3%.

Schuldendekking: De schuld van 002727 wordt goed gedekt door de operationele kasstroom ( 406.7% ).

Rentedekking: De rentebetalingen op de schuld van 002727 worden goed gedekt door EBIT ( 6.2 x dekking).

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y